AxoGen, Inc. (AXGN) Financials

AXGN Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 186.5 million 93.4 million
2023-12-31 196.8 million 101.2 million
2023-09-30 194.6 million 96.8 million
2023-06-30 191.6 million 94.5 million

AXGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -13.6 million ?
2023-12-31 -2.0 million 1.3 million
2023-09-30 -2.3 million 4.7 million
2023-06-30 -4.4 million 5.4 million

AXGN Net Income

No data available :(

AXGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 23.6 million - -
2023-12-31 37.0 million - 22.7 million
2023-09-30 32.6 million - 21.0 million
2023-06-30 34.5 million 46.2 million 21.2 million

AXGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 43.2 million
2023-12-31 43.0 million
2023-09-30 43.0 million
2023-06-30 42.9 million

AXGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 1.3 million 7.4 million 10.0 million 19.8 million
2023-12-31 1.8 million 7.3 million 7.5 million 22.2 million
2023-09-30 3.9 million 7.0 million 8.8 million 21.4 million
2023-06-30 4.7 million 7.4 million 9.6 million 20.8 million

AXGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 41.4 million 8.8 million
2023-12-31 42.9 million 9.2 million
2023-09-30 41.3 million 8.0 million
2023-06-30 38.2 million 7.2 million

AXGN

Price: $5.79

52 week price:
3.45
10.83

Earnings Per Share: -0.51 USD

P/E Ratio: -17.71

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 233500

Ebitda: -1.4 million

Market Capitalization: 253.0 million

Average Dividend Frequency: 1

Links: